David Schnell, Prospect Venture Partners

David Schnell, M.D., is a co-founder and Managing Director of Prospect Venture Partners. See sector focus and contact routes.

About David Schnell

David Schnell, M.D., is a co-founder and Managing Director of Prospect Venture Partners, a Palo Alto-based venture capital firm he established in 1997 after departing Kleiner Perkins Caufield & Byers. The firm focuses exclusively on life sciences, investing in biotechnology, medical devices, and healthcare technology across early- and late-stage companies, including public entities. Initial fund documentation indicated typical investments of $3 million to $5 million per company, with the firm acting as a lead investor in these rounds. Notable portfolio companies include Amicus Therapeutics (NASDAQ: FOLD), a biopharmaceutical firm, and Panmira Pharmaceuticals LLC, where Schnell serves as a Director. Schnell’s distinctive point of view centers on building biomedical companies with proprietary products and innovative technology led by outstanding entrepreneurial teams. His background as a physician (M.D.) complements the firm’s sole focus on health care and biomedical investing.

David Schnell at a glance

Role
Managing Director
Organization
Prospect Venture Partners
Location
Palo Alto, CA
Investor type
Venture Capital
Focus areas
Biotechnology, Health Care, Venture Capital, Biotechnology, Health Care, Pharmaceutical, Medical, Medical Device

Frequently asked about David Schnell

What does David Schnell invest in?
David Schnell at Prospect Venture Partners (Palo Alto, CA) — sector focus: Biotechnology, Health Care, Venture Capital, Biotechnology, Health Care, Pharmaceutical, Medical, Medical Device, Therapeutics, Biopharma, Life Science, Geneti….
How do I contact David Schnell?
David Schnell's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is David Schnell based?
David Schnell is based in Palo Alto, CA.

This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Palo Alto.

Investors similar to David Schnell (20)

Browse related investor lists (2)

Compare David Schnell (8)

Investors like David Schnell · Full investor directory · Investor access · Company funding database

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades